The multimillion-dollar figure was implied by the multinational Takeda and its partner Eli Lilly to explore the health issues that generate 'Actos'.
27 abr 2014 Por: Redacción Vivir
Luego de comprobar que Takeda Pharmaceuticals y Eli Lilly, his associate en Estados Unidos, ocultaran los riesgos de contraer cancer de vejiga que genera Actos, su medicamento contra la diabetes, un jurado de Lafayette (Louisiana) les impuso una fine fine que, en total, US $9.000 millones. A Takeda, the largest pharmaceutical company in Asia whose headquarters are in Tokyo, Japan, will pay US $6,000 million.
The sanction is one of the highest charges against a multinational and opening the doors for which, after this juicio, they compensated hundreds of similar cases that occurred in the light of 1999, when the drug entered the American market.
In the short time I had it, Actos, which turned out to be one of the best options for treating type 2 diabetes, became one of the most popular in the Japanese company. Even, in 2008, in the best year in sales, he recorded US $3.850 million in the world. Calculate that, at the end of this decade I may have generated inputs for US $16,000 million.
But it took just a couple of years more for it to become associated with health problems. Of course, this juice in Lafayette, which lasted after two months, was the heart that was lifted to the head in EE.UU. However, we still don't know with certainty the way in which the Japanese company's payment will be paid for up to 2,700 applicants, if we hope to undertake similar processes in Nevada and Illinois.
On another occasion, the same jurado had paid US $1.500 million in compensatory damages to Terrence Allen, who was guilty of veggie cancer because of the drug.
Without embargo, the directives of the pharmaceuticals rechazaron the decision. In a communication they ensured that all the legal media must be recurred to face the fine. They say, además, that they are capable of demonstrating that they have acted responsibly in informing the public about the concerns associated with Actos, a drug that has been suspended in France and Germany for two years.
And it weighs that the medicine is historical because it is one of the highest taxes on anyone
